CN1617723A - 化合物在睡眠障碍等的治疗、在醒时使精力恢复方面的用途以及治疗与之相伴的头晕眼花的方法 - Google Patents

化合物在睡眠障碍等的治疗、在醒时使精力恢复方面的用途以及治疗与之相伴的头晕眼花的方法 Download PDF

Info

Publication number
CN1617723A
CN1617723A CNA028276256A CN02827625A CN1617723A CN 1617723 A CN1617723 A CN 1617723A CN A028276256 A CNA028276256 A CN A028276256A CN 02827625 A CN02827625 A CN 02827625A CN 1617723 A CN1617723 A CN 1617723A
Authority
CN
China
Prior art keywords
triprolidine
sleep
active ingredient
waking
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028276256A
Other languages
English (en)
Chinese (zh)
Inventor
P·宋德拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of CN1617723A publication Critical patent/CN1617723A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA028276256A 2001-11-30 2002-12-02 化合物在睡眠障碍等的治疗、在醒时使精力恢复方面的用途以及治疗与之相伴的头晕眼花的方法 Pending CN1617723A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0128674.9A GB0128674D0 (en) 2001-11-30 2001-11-30 Treatment of sleep disorders and the like
GB0128674.9 2001-11-30
US10/305,354 US20030134878A1 (en) 2001-11-30 2002-11-27 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
US10/305,354 2002-11-27

Publications (1)

Publication Number Publication Date
CN1617723A true CN1617723A (zh) 2005-05-18

Family

ID=9926729

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028276256A Pending CN1617723A (zh) 2001-11-30 2002-12-02 化合物在睡眠障碍等的治疗、在醒时使精力恢复方面的用途以及治疗与之相伴的头晕眼花的方法

Country Status (13)

Country Link
US (4) US20030134878A1 (enExample)
EP (1) EP1455786A1 (enExample)
JP (1) JP2005515200A (enExample)
CN (1) CN1617723A (enExample)
AU (2) AU2002313364B2 (enExample)
CA (1) CA2468044A1 (enExample)
GB (3) GB0128674D0 (enExample)
IL (1) IL162146A0 (enExample)
NO (1) NO20042389L (enExample)
PL (1) PL370258A1 (enExample)
RU (1) RU2320340C2 (enExample)
WO (1) WO2003047580A1 (enExample)
ZA (1) ZA200404172B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312425D0 (en) * 2003-05-30 2003-07-09 Boots Co Plc Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
WO2005020968A2 (en) * 2003-09-03 2005-03-10 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
KR100870381B1 (ko) 2004-10-14 2008-11-25 다이킨 고교 가부시키가이샤 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
US20070299127A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
BRPI0819819A2 (pt) * 2007-11-21 2015-05-26 Procter & Gamble Preparações, método e kits ùteis para o tratamento de tosse
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
BR112017020307B1 (pt) 2015-03-26 2023-11-07 Jacqueline M. Iversen Usos de uma combinação de naproxeno e fexofenadina
GR1010679B (el) * 2023-02-03 2024-04-26 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση παρακεταμολης υπο μορφη τροχισκων ή παστιλιων με βελτιωτικο γευσης συμβατο με την παρακεταμολη

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4639459A (en) * 1983-02-01 1987-01-27 Burroughs Wellcome Co. Use of trifluoromethyl compounds
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
AR025110A1 (es) * 1999-08-13 2002-11-06 Vela Pharmaceuticals Inc Metodos y composiciones para tratar o prevenir alteraciones del sueno y enfermedades asociadas usando dosis muy bajas de ciclobenzaprina
EP1368000A4 (en) * 2001-03-13 2004-12-01 Penwest Pharmaceuticals Co CHRONOTHERAPEUTIC PHARMACEUTICAL FORMS CONTAINING A GLUCOCORTICOSTEROID
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
PL370258A1 (en) 2005-05-16
RU2320340C2 (ru) 2008-03-27
AU2002350897A1 (en) 2003-06-17
US20070015800A1 (en) 2007-01-18
GB2383537A (en) 2003-07-02
US20040029927A1 (en) 2004-02-12
IL162146A0 (en) 2005-11-20
ZA200404172B (en) 2005-09-01
GB0227708D0 (en) 2003-01-08
GB0128674D0 (en) 2002-01-23
WO2003047580A1 (en) 2003-06-12
AU2002350897B2 (en) 2008-12-11
JP2005515200A (ja) 2005-05-26
NO20042389L (no) 2004-06-08
CA2468044A1 (en) 2003-06-12
GB2383537B (en) 2003-12-10
AU2002313364B2 (en) 2004-02-19
GB0228045D0 (en) 2003-01-08
US20030134878A1 (en) 2003-07-17
US20050282869A1 (en) 2005-12-22
RU2004119832A (ru) 2005-04-20
EP1455786A1 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
CN1842334A (zh) 化合物在睡眠障碍治疗中的用途
CN1309380C (zh) 治疗代谢紊乱、特别是糖尿病或与糖尿病相关的疾病或疾患的药物
CN1293878C (zh) 眼睛疲劳或假性近视预防或治疗剂
CN1290502C (zh) 治疗普通感冒的组合物
CN1592622A (zh) 含有fexofenadine的口溶性片剂
CN1551768A (zh) 新型取代的苯并咪唑剂型及其应用方法
CN1617723A (zh) 化合物在睡眠障碍等的治疗、在醒时使精力恢复方面的用途以及治疗与之相伴的头晕眼花的方法
CN1302605A (zh) 缓释的口服给药组合物
CN1499960A (zh) 时间治疗剂型
EP3645120B1 (en) Nk-1 antagonist compositions and methods for use in treating depression
CN1913876A (zh) 含药物的颗粒和包含这种颗粒的固体制剂
CN1527706A (zh) 含特比萘芬的药物组合物及其应用
CN1679525A (zh) 复方对乙酰氨基酚口腔崩解片
EP3395330B1 (en) Premixture and pharmaceutical composition for the oral administration of memantine as a permanent suspension or prepared prior to administration to the patient, optionally via an enteral feeding tube, and corresponding methods
US20220151998A1 (en) Methods of treating borderline personality disorder
CN1829515A (zh) 曲普立啶提供醒来时精神振作的用途
CN1901890A (zh) 大体线性的泡腾口服芬太尼剂型和施用方法
CN1422162A (zh) 用于治疗伴有咳嗽的过敏和炎症状况的组合物和方法
CN1929822A (zh) 用于递送催眠药穿过口腔粘膜的组合物及其用法
CN101031297A (zh) 眼干燥症和口干燥症治疗用医药组合物
HK1040179A1 (en) Apomorphine-containing dosage forms for ameliorating male erectile dysfunction

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: RECKITT BENCKISER HEALTHCARE (UK) LIMITED

Free format text: FORMER OWNER: THE BOOTS CO. PLC

Effective date: 20070202

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20070202

Address after: Beck County

Applicant after: Reckitt Benckiser Healthcare

Address before: England, Nottingham, England

Applicant before: The Boots Co. PLC

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20050518